The emergence of Parkinson disease among patients with Gaucher disease

被引:12
作者
Elstein, Deborah [1 ]
Alcalay, Roy [2 ,3 ]
Zimran, Ari [1 ]
机构
[1] Hebrew Univ Jerusalem, Sch Med, Shaare Zedek Med Ctr, Gaucher Clin, IL-91010 Jerusalem, Israel
[2] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA
[3] Columbia Univ, Med Ctr, Taub Inst, New York, NY USA
关键词
alpha-synuclein; beta-glucocerebrosidase; Gaucher disease; Parkinson disease; GBA MUTATION CARRIERS; ALPHA-SYNUCLEIN; GLUCOCEREBROSIDASE MUTATIONS; EARLY-ONSET; PHARMACOLOGICAL CHAPERONE; RISK-FACTOR; GENE; AMBROXOL; OSTEOPONTIN; ASSOCIATION;
D O I
10.1016/j.beem.2014.08.007
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the last decade, several lines of evidence have been presented that document the clinical manifestations, genetic associations, and subcellular mechanisms of the inter-relatedness of beta-glucocerebrosidase mutations and the emergence of Parkinson disease among carriers and patients with Gaucher disease. This review is an attempt to apprise the reader of the recent literature with the caveat that this is an area of intensive exploration that is constantly being updated because of the immediate clinical ramifications but also because of the impact on our understanding of Parkinson disease, and finally because of the unexpected inter-reactions between these entities on the molecular level. It has been an unexpected happenstance that it has been discovered that a rare monogenetic disease has an interface at many points with a neurological disorder of the elderly that has both familial and sporadic forms: to date there is no cure for either of these disorders. (C). 2014 Elsevier Ltd. All rights reserved.
引用
收藏
页码:249 / 259
页数:11
相关论文
共 79 条
  • [41] Identification and Characterization of Ambroxol as an Enzyme Enhancement Agent for Gaucher Disease
    Maegawa, Gustavo H. B.
    Tropak, Michael B.
    Buttner, Justin D.
    Rigat, Brigitte A.
    Fuller, Maria
    Pandit, Deepangi
    Tang, Liangiie
    Kornhaber, Gregory J.
    Hamuro, Yoshitomo
    Clarke, Joe T. R.
    Mahuran, Don J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (35) : 23502 - 23516
  • [42] Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model
    Maetzler, Walter
    Berg, Daniela
    Schalamberidze, Natalie
    Melms, Arthur
    Schott, Klaus
    Mueller, Jakob C.
    Liaw, Lucy
    Gasser, Thomas
    Nitsch, Cordula
    [J]. NEUROBIOLOGY OF DISEASE, 2007, 25 (03) : 473 - 482
  • [43] A single-nucleotide polymorphism of the osteopontin gene may contribute to a susceptibility to Lewy body disease
    Maetzler, Walter
    Michelis, Joan
    Tomiuk, Juergen
    Melms, Arthur
    Becker, Clemens
    Gasser, Thomas
    Schulte, Claudia
    Berg, Daniela
    [J]. JOURNAL OF NEURAL TRANSMISSION, 2009, 116 (05) : 599 - 605
  • [44] Glucocerebroside treatment ameliorates ConA hepatitis by inhibition of NKT lymphocytes
    Margalit, M
    Abu Ghazala, S
    Alper, R
    Elinav, E
    Klein, A
    Doviner, V
    Sherman, Y
    Thalenfeld, B
    Engelhardt, D
    Rabbani, E
    Ilan, Y
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY, 2005, 289 (05): : G917 - G925
  • [45] Glucocerebrosidase gene mutations - A risk factor for Lewy body disorders
    Mata, Ignacio F.
    Samii, Ali
    Schneer, Seth H.
    Roberts, John W.
    Griffith, Alida
    Leis, Berta C.
    Schellenberg, Gerard D.
    Sidransky, Ellen
    Bird, Thomas D.
    Leverenz, James B.
    Tsuang, Debby
    Zabetian, Cyrus P.
    [J]. ARCHIVES OF NEUROLOGY, 2008, 65 (03) : 379 - 382
  • [46] Ambroxol improves lysosomal biochemistry in glucocerebrosidase mutation-linked Parkinson disease cells
    McNeill, Alisdair
    Magalhaes, Joana
    Shen, Chengguo
    Chau, Kai-Yin
    Hughes, Derralyn
    Mehta, Atul
    Foltynie, Tom
    Cooper, J. Mark
    Abramov, Andrey Y.
    Gegg, Matthew
    Schapira, Anthony H. V.
    [J]. BRAIN, 2014, 137 : 1481 - 1495
  • [47] A Multicenter Study of Glucocerebrosidase Mutations in Dementia With Lewy Bodies
    Nalls, Michael A.
    Duran, Raquel
    Lopez, Grisel
    Kurzawa-Akanbi, Marzena
    McKeith, Ian G.
    Chinnery, Patrick F.
    Morris, Christopher M.
    Theuns, Jessie
    Crosiers, David
    Cras, Patrick
    Engelborghs, Sebastiaan
    De Deyn, Peter Paul
    Van Broeckhoven, Christine
    Mann, David M. A.
    Snowden, Julie
    Pickering-Brown, Stuart
    Halliwell, Nicola
    Davidson, Yvonne
    Gibbons, Linda
    Harris, Jenny
    Sheerin, Una-Marie
    Bras, Jose
    Hardy, John
    Clark, Lorraine
    Marder, Karen
    Honig, Lawrence S.
    Berg, Daniela
    Maetzler, Walter
    Brockmann, Kathrin
    Gasser, Thomas
    Novellino, Fabiana
    Quattrone, Aldo
    Annesi, Grazia
    De Marco, Elvira Valeria
    Rogaeva, Ekaterina
    Masellis, Mario
    Black, Sandra E.
    Bilbao, Juan M.
    Foroud, Tatiana
    Ghetti, Bernardino
    Nichols, William C.
    Pankratz, Nathan
    Halliday, Glenda
    Lesage, Suzanne
    Klebe, Stephan
    Durr, Alexandra
    Duyckaerts, Charles
    Brice, Alexis
    Giasson, Benoit I.
    Trojanowski, John Q.
    [J]. JAMA NEUROLOGY, 2013, 70 (06) : 727 - 735
  • [48] Neudorfer O, 1996, QJM-MON J ASSOC PHYS, V89, P691
  • [49] Neudorfer O, 1994, THESIS HEBREW U
  • [50] Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
    Nichols, W. C.
    Pankratz, N.
    Marek, D. K.
    Pauciulo, M. W.
    Elsaesser, V. E.
    Halter, C. A.
    Rudolph, A.
    Wojcieszek, J.
    Pfeiffer, R. F.
    Foroud, T.
    [J]. NEUROLOGY, 2009, 72 (04) : 310 - 316